共 50 条
- [21] Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trialEUROPEAN JOURNAL OF CANCER, 2020, 124 : 178 - 185Jones, David A.Mistry, PankajDalby, MatthewFulton-Lieuw, TessaKong, Anthony H.Dunn, JanetMehanna, Hisham M.Gray, Alastair M.
- [22] Commentary on: Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Program of All-Inclusive Care for the ElderlyJOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (06) : 2008 - 2010Snyder, DanielMujais, Salim
- [23] Comment on: Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the ElderlyJOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (03) : 994 - 996Snyder, DanielMujais, Salim
- [24] Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatmentsJOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (01) : 71 - 79Esgueva, AntonioSiso, ChristianEspinosa-Bravo, MartinSobrido, CarolinaMiranda, IgnacioSalazar, Juan P.Rubio, Isabel T.
- [25] Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialLANCET, 2019, 393 (10166): : 51 - 60Mehanna, HishamRobinson, MaxHartley, AndrewKong, AnthonyForan, BernadetteFulton-Lieuw, TessaDalby, MatthewMistry, PankajSen, MehmetO'Toole, LorcanAl Booz, HodaDyker, KarenMoleron, RafaelWhitaker, StephenBrennan, SineadCook, AudreyGriffin, MatthewAynsley, EleanorRolles, MartinDe Winton, EmmaChan, AndrewSrinivasan, DevrajNixon, IoannaGrumett, JoanneLeemans, C. ReneButer, JanHenderson, JuliaHarrington, KevinMcConkey, ChristopherGray, AlastairDunn, Janet
- [26] De-ESCALaTE: Comparison of early and late toxic events in low-risk HPV positive oropharyngeal carcinoma patients treated with chemoradiotherapy, cetuximab versus cisplatin.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Mehanna, Hisham MohamedMcConkey, Christopher C.Hartley, Andrew G. J.Fulton-Lieuw, M. TessaGrumett, JoanneRobinson, MaxForan, BernadetteSen, MehmetKong, AnthonyDunn, Janet
- [27] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTEEuropean Archives of Oto-Rhino-Laryngology, 2019, 276 : 2113 - 2114Petar SutonMarko SkelinZoran RakusicStjepan DokuzovicIvica Luksic
- [28] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTEEUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 2113 - 2114Suton, PetarSkelin, MarkoRakusic, ZoranDokuzovic, StjepanLuksic, Ivica
- [29] Clinicopathologic Evaluation of Triple Negative Breast Cancer Treated with Neoadjuvant Immune- and Chemo- Therapy: Attempt to De-Escalate TreatmentLABORATORY INVESTIGATION, 2023, 103 (03) : S154 - S155Khoury, ThaerTozbikian, GaryFadare, OluwoleFang, YishengSyed, SamiraAttwood, KristopherGandhi, Shipra
- [30] Identification of good and poor prognosis HPV associated oropharyngeal cancer based on CD103 immune cell expression in patients treated with cetuximab and radiotherapy on TROG 12.01 and De-ESCALaTE randomized trials.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Rischin, DannyMehanna, Hisham MohamedYoung, Richard J.Bressel, MathiasDunn, JanetCorry, JuneFulton-Lieuw, TessaIqbal, GulnazKenny, Lizbeth M.Porceddu, SandroWratten, ChristopherRobinson, MaxSolomon, Benjamin J.